The Transformative Potential of Genomic Medicine 2.0

Transformative Potential of Genomic Medicine
The Transformative Potential of Genomic Medicine 2.0
November 10, 2021

The Biotechnology Innovation Organization (BIO) and BioFlorida present "The Transformative Potential of Genomic Medicine 2.0." Genomic technologies create powerful tools that have the potential to diagnose, treat, and permanently subdue many human diseases. Technologies such as gene therapy, gene editing, and CRISPR are just some of the newest terms as researchers and clinicians work on new approaches to develop lifesaving, disease-altering treatments. This session provides in-depth discussion regarding how treatment is changing in rare diseases and the sickle cell community, and how public and private payers are approaching coverage of these crucial treatments. The session opens with statements from two legislators, then the panel features two patients and an expert in alternative payment models to provide information and answer questions from policymakers.  

Representative Sam Garrison
Florida House of Representatives
House Health and Human Services Committee Republican Majority Whip

Senator Bobby Powell
Florida State Senate
Legislative Black Caucus Chair

Moderators & Speakers
Placeholder Image
Ben Chandhok, Moderator
State Government Affairs Director, Eastern Region
Placeholder Image
Nancy Bryan
President & CEO
Placeholder Image
Carla Lewis
CEO & Founder
Kids Conquering Sickle Cell Disease Foundation
Placeholder Image
Christina Mennella
Advocate Cure
Placeholder Image
Mark Trusheim
Strategic Director
NEWDIGS at MIT Center for Biomedical Innovation